Search Full Text
Now showing items 21-30 of 126
Being a Messenger of Life-Threatening Conditions: Experiences of Pediatric Oncologists
(2010-09)
BACKGROUND: A nationwide population-based study with questionnaires involving 90 pediatric oncologists was performed in Sweden in 2006/2007. On the basis of this quantitative study, a qualitative study was performed. The ...
A History of Resolving Conflicts Over End-of-Life Care in Intensive Care Units in the United States
(2010-08)
OBJECTIVES: To present a case of conflict over end-of-life care in the intensive care unit (ICU) and to describe how such conflicts have been resolved in the United States since the inception of ICUs. DATA SOURCES: A ...
When Enough Is Enough; Terminating Life-Sustaining Treatment at the Patient's Request: A Survey of Attitudes Among Swedish Physicians and the General Public
(2010-05)
OBJECTIVES: To explore attitudes and reasoning among Swedish physicians and the general public regarding the withdrawal of life-sustaining treatment at a competent patient's request. DESIGN: A vignette-based postal ...
Dutch Experience of Monitoring Active Ending of Life for Newborns
(2010-04)
INTRODUCTION: In 2007, a national review committee was instituted in The Netherlands to review cases of active ending of life for newborns. It was expected that 15-20 cases would be reported. To date, however, only one ...
The "PSOST": Providers' Signout for Scope of Treatment
(2010-09)
Palliative care provides open and honest communication, medically appropriate goal setting, and meticulous attention to symptom assessment and control. The Physicians Orders for Life Sustaining Treatment (POLST) is a growing ...
The Metamorphosis of Managed Care: Implications for Health Reform Internationally
(2010-06)
The conventional wisdom is that managed care's brief life is over and we are now in a post-managed care era. In fact, managed care has a long history and continues to thrive. Writers also often assume that managed care is ...
Ethical and Value Issues in Insurance Coverage for Cancer Treatment
(2010)
Many new cancer drugs provide only limited benefits, but at very great cost, for example, $200,000-$300,000 per quality-adjusted life year produced. By most standards of value or cost-effectiveness, this does not represent ...
Documentation of Best Interest by Intensivists: A Retrospective Study in an Ontario Critical Care Unit
(2010-02-10)
BACKGROUND: Intensive care physicians often must rely on substitute decision makers to address all dimensions of the construct of "best interest" for incapable, critically ill patients. This task involves identifying prior ...
Moral Fictions and Medical Ethics
(2010-11)
Conventional medical ethics and the law draw a bright line distinguishing the permitted practice of withdrawing life-sustaining treatment from the forbidden practice of active euthanasia by means of a lethal injection. ...
Assisted Suicide Laws Create Discriminatory Double Standard for Who Gets Suicide Prevention and Who Gets Suicide Assistance: Not Dead Yet Responds to Autonomy, Inc
(2010-01)
Not Dead Yet is a national disability rights organization formed in 1996 to articulate and organize the disability rights opposition to legalization of assisted suicide. In the first half of 2009, Not Dead Yet and four ...